In the News

21 June 2012 | The Hedge Fund Journal

Bernheim, Dreyfus get acceleration capital

Diva Synergy UCITS, the Event Driven fund managed by Bernheim, Dreyfus & Co, received approximately $40 million of acceleration capital from the newly launched seeding platform Emergence, bringing its assets to approximately $50 million.

 “We are extremely pleased to be part of the Emergence project and to have been chosen by NewAlpha, which has a strong track-record of identifying solid, high-potential managers through their extensive and rigorous selection process,” said Amit Shabi, co-manager of the fund. “We believe that we are perfectly positioned to generate strong risk-adjusted returns in the future and that the Emergence investment will significantly contribute to the fund’s growth.”

21 June 2012 | FINalternatives

Bernheim Dreyfus Receives $40M Seed Investment

Mergers and acquisitions specialist Bernheim, Dreyfus & Co. has received a $40 million cash injection from the newly launched seeding platform Emergence.

The acceleration capital brings total assets under management in the Diva Synergy UCITS event-driven fund, run by Lionel Melka, Amit Shabi and Sébastien Dettmar, to about $50 million.

21 June 2012 | Hedge Fund Intelligence

Bernheim, Dreyfus gets €30m seeding boost from Emergence

Emergence, the nascent French seeding platform backed by seven of the country’s largest institutional investors, has made its second hedge fund investment – allocating €30 million to the UCITS version of Diva Synergy, the merger arbitrage and pre-event strategy managed by Paris-based Bernheim, Dreyfus & Co.

Philippe Paquet, deputy CEO of NewAlpha, told EuroHedge that he considers Bernheim, Dreyfus to be one of the best Europe-based managers in the merger arb/event-driven space, displaying a deep and comprehensive knowledge of the European M&A market.

“They have a very strong and institutional set-up and background story, but they were in need of some marketing and some attention from the market,” he said. “I think that’s somewhere that Emergence can add value.”


18 April 2012 | MarketWatch

Amit Shabi comments on the Roche - Illumina deal

War for Illumina could resume

"I personally believe that this battle is not over," said Amit Shabi, who co-manages the Paris-based Bernheim Dreyfus Diva Synergy fund.

|  9 |  10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34